• Epidermolysis Bullosa (EB) also known as the “butterfly children” condition is a rare genetic disease of the skin with highly disabling effects and which is ultimately fatal for patients who suffer it.

Genetrix, Cellerix, Inbiomed foundation and Spanish Association of Epidermolysis Bullosa are developing Phase II clinical research for Cx501 to treat this disease thanks to funding of the bank La Kutxa's Social Work Programme.